Overview on Renovascular Hypertension: Review Article

Mohammed Salah Hussein *

Department of Gastroenterology and Endoscopy, Dr Samir Abbas Hospital, Jeddah, Saudi Arabia and Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Almutairi, Samia Nouh

King Abdulaziz University, Saudi Arabia.

Azam Mohammed Alnamy

King Abdulaziz University, Saudi Arabia.

Alsulami, Roaya Ayed

King Abdulaziz University, Saudi Arabia.

Zainab Ali Alshaikh

Arabian Gulf University, Saudi Arabia.

Abdulaziz Homoud A. Alrethaia

King Abdulaziz University, Saudi Arabia.

Lamia Abdulaziz Aljeraisy

King Saud Medical City, Saudi Arabia.

Thekra Zaidan albalawi

Tabuk University, Saudi Arabia.

Ethar Abdulrahman H. Almohseny

King Khalid University, Saudi Arabia.

Fatimah Turki AlGhamdi

Al Amal Complex for Mental Health, Dammam, Saudi Arabia.

Alrayuf Mohammad Alothri

Tumair General Hospital, Tumair, Saudi Arabia.

Alotaibi, Turki Abdulelah R

Communicable Disease Control Directorate, Taif, Saudi Arabia.

Ali Aziz Al-sayed

Al-qunfudah General Hospital, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Renovascular hypertension (RVH) is a prevalent cause of secondary hypertension that frequently develops to resistant hypertension. It is characterised as systemic hypertension that develops as a result of a restricted blood supply to the kidneys. Patients cannot be recognized clinically from those with essential hypertension; therefore, diagnosis requires arteriography, however urography and isotope renography may hint to the diagnosis. Atherosclerotic renal artery stenosis (ARAS) and fibromuscular dysplasia are the two most prevalent causes of RVH. The ultimate objective of controlling RVH, like with other kinds of hypertension, is to minimize the morbidity and mortality associated with high blood pressure The widespread use of effective antihypertensive medication treatment, statins, and other strategies to control vascular disease has resulted in remarkable improvements. In this review we will be looking at etiology, pathogenesis and treatment or RVH.

Keywords: Renovascular hypertension, ARAS, fibromuscular dysplasia, arteriography


How to Cite

Hussein, M. S., Nouh, A. S., Alnamy, A. M., Ayed, A. R., Alshaikh, Z. A., Alrethaia, A. H. A., Aljeraisy, L. A., albalawi, T. Z., Almohseny, E. A. H., AlGhamdi, F. T., Alothri, A. M., R, A. T. A. and Al-sayed, A. A. (2021) “Overview on Renovascular Hypertension: Review Article”, Journal of Pharmaceutical Research International, 33(56B), pp. 15–22. doi: 10.9734/jpri/2021/v33i56B33922.